Categories: News

ChannelAdvisor to Announce Fourth Quarter and Full Year 2020 Financial Results on February 11, 2021

RESEARCH TRIANGLE PARK, N.C., Jan. 28, 2021 (GLOBE NEWSWIRE) — ChannelAdvisor Corporation (NYSE: ECOM), a leading provider of cloud-based e-commerce solutions, today announced it will release its fourth quarter and full year 2020 financial results for the period ending December 31, 2020 before 8:00 a.m. ET on Thursday, February 11, 2021. On that day, management will hold a conference call and webcast at 8:00 a.m. ET to review and discuss the results for the periods. A recorded version of this webcast will be available after the call and accessible at http://ir.channeladvisor.com.

   
What:  ChannelAdvisor Fourth Quarter and Full Year 2020 Financial Results Conference Call
   
When: Thursday, February 11, 2021
   
Time: 8:00 a.m. ET
   
Live Call: (855) 638-4821, Passcode 6076252, Toll Free
  (704) 288-0612, Passcode 6076252, Toll
   
Webcast: http://ir.channeladvisor.com (live and replay)
   

About ChannelAdvisor
ChannelAdvisor (NYSE: ECOM) is a leading e-commerce cloud platform whose mission is to connect and optimize the world’s commerce. For nearly two decades, ChannelAdvisor has helped brands and retailers worldwide improve their online performance by expanding sales channels, connecting with consumers around the world, optimizing their operations for peak performance, and providing actionable analytics to improve competitiveness. Thousands of customers depend on ChannelAdvisor to securely power their sales and optimize fulfillment on channels such as Amazon, eBay, Google, Facebook, Walmart, and hundreds more.  For more information, visit www.channeladvisor.com.

CONTACT: Investor Contact:
ChannelAdvisor Corporation
Raiford Garrabrant
+1 (919) 228-4817
raiford.garrabrant@channeladvisor.com

or

Media Contact:
ChannelAdvisor Corporation
Tamara Gibbs
+1 (919) 249-9798
tamara.gibbs@channeladvisor.com

Staff

Recent Posts

Vaxxas Secures TGA Licence to Manufacture Therapeutic Goods

Milestone enables GMP manufacturing to accelerate clinical trials and transform global vaccine delivery BRISBANE, Australia…

17 hours ago

InnoCare Announces Achievement of Primary Endpoint in Phase IIb Study of Orelabrutinib for SLE and Approval of Phase III Clinical Trial

BEIJING, Dec. 14, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading…

17 hours ago

President Trump’s Cannabis Decision Is Coming – And Why MMJ International Holdings Wins Either Way

12 Month Timeline - How Cannabis Rescheduling Actually Takes EffectAnnouncementPresident signals intent or issues executive…

1 day ago

Accelerating Patient Recruitment and Research Excellence: TrialWire® Supports Endpoints Clinical Trials Day NYC 2025

NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- TrialWire®, the industry’s fastest, intelligent patient recruitment…

2 days ago

Genesis Healthcare Remains Committed to Securing Longterm Stability

The skilled nursing, assisted and senior living provider reiterates dedication to a financial restructuring process…

2 days ago